Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2008

View Archived Issues

New therapeutic approach against toxoplasmosis reported

MicroRNA mimics suppress Bcr-Abl expression in vitro and in vivo

Phase II trial of Hsp90 inhibitor alvespimycin begins in HER2+ metastatic breast cancer

Data support therapeutic role for buprenorphine in neuropathic pain

Allon initiates phase I clinical trial of AL-108 and AL-208

Three Rivers acquires hepatitis C drug Infergen from Valeant

Vasopressin V2 receptor agonists prepared and tested at Kissei

Roche responds to the results of the IDEAL hepatitis C trial reported

Upstream enters agreement with MSU for drug candidates for tropical parasitic diseases

FDA grants approval to DAKO to market the TOP2A FISH pharmDx breast-cancer test

Gabriel Sciences receives grant from NIH for development of lead antidepressant compound

Alfacell licenses U.S. commercial rights to Onconase to Strativa Pharmaceuticals

Taranabant induces weight loss in obese subjects

Novartis Pharma and Mitsubishi Tanabe revise agreement for Lochol for hypercholesteremia

Genzyme enters license agreement with Moffitt Cancer Center for lung cancer diagnostic

Tolerx receives payment from Genentech following phase Ib clinical study of TRX-1

Anthera reports positive preliminary results from phase IIb clinical trial of A-002

Celsion to proceed with phase II pivotal breast cancer trial

Protox Therapeutics commences phase IIa PRX-302 trial in prostate cancer

Summit's lead drug candidate, SMT-D001, enters phase II clinical trials

Recent patents describe novel analgesic agents

Remicade label enhancement receives E.U. approval in Crohn's disease

E.U. marketing authorization granted for GSK's Avamys for allergic rhinitis therapy

E.C. grants Remicade label enhancement for ankylosing spondylitis and psoriatic arthritis

New oncolytic drugs described in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...